Vasamed, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSMD research report →
Companywww.vasamed.com
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system.
- CEO
- Paulita LaPlante
- IPO
- 1996
- HQ
- Eden Prairie, MN, US
Price Chart
Valuation
- Market Cap
- $802
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -5.01%
- Op Margin
- 342.08%
- Net Margin
- -352.61%
- ROE
- 315.37%
- ROIC
- 742.82%
Growth & Income
- Revenue
- $1.39M · 29.66%
- Net Income
- $-4,888,153 · 23.88%
- EPS
- $-1.31 · 29.19%
- Op Income
- $4.74M
- FCF YoY
- -21.52%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.02
- Avg Volume
- 35.64
Get TickerSpark's AI analysis on VSMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our VSMD Coverage
We haven't published any research on VSMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VSMD Report →